2Shi GP,Sukhova GK,Grubb A,et al.Cystatin C deficiency in human atherosclerosis and aortic aneurysms[J].J Clin Invest,1999,104(9):1191-1197.
3Cheng XW,Kuzuya M,Sasaki T,et al.Increased expression of elastolytic cysteine proteases,cathepsins S and K,in the neointima of balloon-injured rat carotid arteries[J].Am J Pathol,2004,164(1):243-251.
4Sukhova GK,Wang B,Libby P,et al.Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice[J].Circ Res,2005,96(3):368-375.
5Nakamura K,Okamura T,Hayakawa T,et al.Chronic kidney disease is a risk factor of cardiovascular death in a community-based population in Japan:NIPPON DATA90[J].Circ J,2006,70(8):954-959.
6Go AS,Chertow GM,Fan D,et al.Chronic kidney disease and the risks of death,cardiovascular events,and hospitalization[J].N Engl J Med,2004,351(13):1296-1305.
7Bibbins-Domingo K,Lin F,Vittinghoff E,et al.Predictors of heart failure among women with coronary disease[J].Circulation,2004,110(11):1424-1430.
8Anavekar NS,McMurray JJ,Velazquez EJ,et al.Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction[J].N Engl J Med,2004,351(13):1285-1295.
9Dharnidharka VR,Kwon C,Stevens G.Serum cystatin C is superior to serum creatinine as a marker of kidney function:a meta-analysis[R].Am J Kidney Dis,2002,40(2):221-226.
10Hillege HL,Verhave JC,Bakker SJ,et al.Cystatin C,a novel risk marker for mortality in the general population:data obtained from the PREVEND study[J].Vasc Dis Hypertens Prevention,2004,519(A):1159-1194.
